New Recommendations on This Dreaded Complication

Interstitial lung disease (ILD) is characterized by pulmonary fibrosis and/or inflammation and is considered a serious extra-articular manifestation of rheumatoid arthritis (RA). Up to 15% of RA patients develop clinically significant ILD, and an even greater number have subclinical disease (imaging findings without symptoms). A multidisciplinary group of international experts reviewed the currently available evidence and developed consensus recommendations for clinical practice.